Becker R E, Giambalvo C, Fox R A, Macho M
Science. 1983 Jul 29;221(4609):476-8. doi: 10.1126/science.6867724.
Inhibitory activity against the enzyme monoamine oxidase is present in low molecular weight fractions (less than 100,000) of human cerebrospinal fluid. These endogenous substances of different molecular weights (3000 to more than 35,000) act like monoamine oxidase inhibitor drugs to inhibit both type A and type B monoamine oxidase.
人脑脊液的低分子量组分(小于100,000)中存在对单胺氧化酶的抑制活性。这些不同分子量(3000至超过35,000)的内源性物质的作用类似于单胺氧化酶抑制药物,可抑制A型和B型单胺氧化酶。